Yong Ding

Prof. Dr. Yong Ding


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 June 2020 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
XZXiuming Zhang
Xiuming Zhang
SRShijian Ruan
Shijian Ruan
WXWenbo Xiao
Wenbo Xiao
JSJiayuan Shao
Jiayuan Shao
WTWuwei Tian
Wuwei Tian
TLTingbo Liang
Tingbo Liang
Background: The present study constructed and validated the use of contrast‐enhanced computed tomography (CT)‐based radiomics to preoperatively predict microvascular invasion (MVI) status (positive vs negative) and risk (low vs high) in patients with hepatocellular carcinoma (HCC).Methods: We enrolled 637 patients from two independent institutions. Patients from Institution I were randomly divided into a training cohort of 451 patients and a test cohort of 111 patients. Patients from Institution II served as an independent validation set. The LASSO algorithm was used for the selection of 798 radiomics features. Two classifiers for predicting MVI status and MVI risk were developed using multivariable logistic regression. We also performed a survival analysis to investigate the potentially prognostic value of the proposed MVI classifiers.Results: The developed radiomics signature predicted MVI status with an area under the receiver operating characteristic curve (AUC) of .780, .776, and .743 in the training, test, and independent validation cohorts, respectively. The final MVI status classifier that integrated two clinical factors (age and α‐fetoprotein level) achieved AUC of .806, .803, and .796 in the training, test, and independent validation cohorts, respectively. For MVI risk stratification, the AUCs of the radiomics signature were .746, .664, and .700 in the training, test, and independent validation cohorts, respectively, and the AUCs of the final MVI risk classifier‐integrated clinical stage were .783, .778, and .740, respectively. Survival analysis showed that our MVI status classifier significantly stratified patients for short overall survival or early tumor recurrence.Conclusions: Our CT radiomics‐based models were able to predict MVI status and MVI risk of HCC and might serve as a reliable preoperative evaluation tool.

24 August 2021 in IEEE Journal of Solid-State Circuits
Verified
Journal Article
Closed access
HCHaixiao Cao
Haixiao Cao
XYXu Yang
Xu Yang
CXChenkang Xue
Chenkang Xue
LHLenian He
Lenian He
ZTZhichao Tan
Zhichao Tan
WQWanyuan Qu
Wanyuan Qu
This work presents a 48-1V dc–dc converter with an on-chip switch and gallium nitride (GaN) hybrid power conversion. By series connecting a 12-level Dickson switched-capacitor with a two-phase switched-inductor circuit, the capacitors take over most of the 48-V voltage stresses. The circuit, thus, reduces to an equivalent 4-1V converter, making the on-chip 5-V transistor applicable for a 48-V high-voltage design. Due to the easy integration of on-chip switches and superior switch figures of merit over other 48-1V counterparts, this proposed design is able to achieve the highest switching frequency, the lowest external switch count, and the improved power density compared with other prior-state-of-the-arts. The prototype was fabricated using a 0.18- $\mu \text{m}$ BCD process with an evaluation board volume of 17 mm $\times $ 15 mm $\times $ 2.6 mm. The converter achieves a maximum 8-A loading capacity with the input range from 36 to 60 V and the output from 0.5 to 1 V. The measured peak power efficiency is 90.2%, and the power density is 998 A/in 3 considering the power stage volume.

29 November 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
WLWenjie Liang
Wenjie Liang
WTWuwei Tian
Wuwei Tian
YWYifan Wang
Yifan Wang
PWPan Wang
Pan Wang
YWYubizhuo Wang
Yubizhuo Wang
XBXueli Bai
Xueli Bai
Background: Preoperative prediction of pancreatic cystic neoplasm (PCN) differentiation has significant value for the implementation of personalized diagnosis and treatment plans. This study aimed to build radiomics deep learning (DL) models using computed tomography (CT) data for the preoperative differential diagnosis of common cystic tumors of the pancreas. Methods: Clinical and CT data of 193 patients with PCN were collected for this study. Among these patients, 99 were pathologically diagnosed with pancreatic serous cystadenoma (SCA), 55 were diagnosed with mucinous cystadenoma (MCA) and 39 were diagnosed with intraductal papillary mucinous neoplasm (IPMN). The regions of interest (ROIs) were obtained based on manual image segmentation of CT slices. The radiomics and radiomics-DL models were constructed using support vector machines (SVMs). Moreover, based on the fusion of clinical and radiological features, the best combined feature set was obtained according to the Akaike information criterion (AIC) analysis. Then the fused model was constructed using logistic regression. Results: For the SCA differential diagnosis, the fused model performed the best and obtained an average area under the curve (AUC) of 0.916. It had a best feature set including position, polycystic features (≥6), cystic wall calcification, pancreatic duct dilatation and radiomics-DL score. For the MCA and IPMN differential diagnosis, the fused model with AUC of 0.973 had a best feature set including age, communication with the pancreatic duct and radiomics score. Conclusions: The radiomics, radiomics-DL and fused models based on CT images have a favorable differential diagnostic performance for SCA, MCA and IPMN. These findings may be beneficial for the exploration of individualized management strategies.


26 June 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JHJiacheng Huang
Jiacheng Huang
WTWuwei Tian
Wuwei Tian
LZLele Zhang
Lele Zhang
QHQiang Huang
Qiang Huang
SLShengzhang Lin
Shengzhang Lin
SZShusen Zheng
Shusen Zheng
Background: To compare the predictive power between radiomics and non-radiomics (conventional imaging and functional imaging methods) for preoperative evaluation of microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Methods: Comprehensive publications were screened in PubMed, Embase, and Cochrane Library. Studies focusing on the discrimination values of imaging methods, including radiomics and non-radiomics methods, for MVI evaluation were included in our meta-analysis. Results: Thirty-three imaging studies with 5,462 cases, focusing on preoperative evaluation of MVI status in HCC, were included. The sensitivity and specificity of MVI prediction in HCC were 0.78 [95% confidence interval (CI): 0.75–0.80; I2 = 70.7%] and 0.78 (95% CI: 0.76–0.81; I2 = 0.0%) for radiomics, respectively, and were 0.73 (95% CI: 0.71–0.75; I2 = 83.7%) and 0.82 (95% CI: 0.80–0.83; I2 = 86.5%) for non-radiomics, respectively. The areas under the receiver operation curves for radiomics and non-radiomics to predict MVI status in HCC were 0.8550 and 0.8601, respectively, showing no significant difference. Conclusion: The imaging method is feasible to predict the MVI state of HCC. Radiomics method based on medical image data is a promising application in clinical practice and can provide quantifiable image features. With the help of these features, highly consistent prediction performance will be achieved in anticipation.